PERINDOPRIL ERBUMINE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for perindopril erbumine and what is the scope of freedom to operate?
Perindopril erbumine
is the generic ingredient in two branded drugs marketed by Symplmed Pharms Llc, Ani Pharms, Apotex, Aurobindo Pharma, Hikma, and Lupin Ltd, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.There are five drug master file entries for perindopril erbumine. One supplier is listed for this compound.
Summary for PERINDOPRIL ERBUMINE
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 6 |
NDAs: | 6 |
Drug Master File Entries: | 5 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 80 |
Clinical Trials: | 3 |
Patent Applications: | 3,113 |
Drug Prices: | Drug price trends for PERINDOPRIL ERBUMINE |
What excipients (inactive ingredients) are in PERINDOPRIL ERBUMINE? | PERINDOPRIL ERBUMINE excipients list |
DailyMed Link: | PERINDOPRIL ERBUMINE at DailyMed |
Recent Clinical Trials for PERINDOPRIL ERBUMINE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Symplmed Pharmaceuticals LLC | Phase 3 |
Roxane Laboratories | N/A |
Pharmacology for PERINDOPRIL ERBUMINE
Drug Class | Angiotensin Converting Enzyme Inhibitor |
Mechanism of Action | Angiotensin-converting Enzyme Inhibitors |
Medical Subject Heading (MeSH) Categories for PERINDOPRIL ERBUMINE
Anatomical Therapeutic Chemical (ATC) Classes for PERINDOPRIL ERBUMINE
Paragraph IV (Patent) Challenges for PERINDOPRIL ERBUMINE
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
ACEON | Tablets | perindopril erbumine | 2 mg, 4 mg and 8 mg | 020184 | 1 | 2006-06-06 |
US Patents and Regulatory Information for PERINDOPRIL ERBUMINE
Expired US Patents for PERINDOPRIL ERBUMINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Symplmed Pharms Llc | ACEON | perindopril erbumine | TABLET;ORAL | 020184-003 | Dec 30, 1993 | ⤷ Sign Up | ⤷ Sign Up |
Symplmed Pharms Llc | ACEON | perindopril erbumine | TABLET;ORAL | 020184-001 | Dec 30, 1993 | ⤷ Sign Up | ⤷ Sign Up |
Symplmed Pharms Llc | ACEON | perindopril erbumine | TABLET;ORAL | 020184-002 | Dec 30, 1993 | ⤷ Sign Up | ⤷ Sign Up |
Symplmed Pharms Llc | ACEON | perindopril erbumine | TABLET;ORAL | 020184-001 | Dec 30, 1993 | ⤷ Sign Up | ⤷ Sign Up |
Symplmed Pharms Llc | ACEON | perindopril erbumine | TABLET;ORAL | 020184-002 | Dec 30, 1993 | ⤷ Sign Up | ⤷ Sign Up |
Symplmed Pharms Llc | ACEON | perindopril erbumine | TABLET;ORAL | 020184-003 | Dec 30, 1993 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.